Jonathan Douxfils

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

Dose-Finding Study of Rivaroxaban in Hemodialysis Patients

Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013

Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays

The role of the laboratory in treatment with new oral anticoagulants

Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update

Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants

Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and Apixaban

Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays

Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban

Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia

Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition

Macrophages as regulators of tumour immunity and immunotherapy

Removal of organic contaminants from secondary effluent by anodic oxidation with a boron-doped diamond anode as tertiary treatment

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

Heparin‐induced multi‐electrode aggregometry method for heparin‐induced thrombocytopenia testing: communication from the SSC of the ISTH

Heparin-Induced Thrombocytopenia

More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate

Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation

Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy

Beneficial roles of feed additives as immunostimulants in aquaculture: a review

The pros and cons of ecological risk assessment based on data from different levels of biological organization

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Frequent False‐positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin

Preserving environmental health and scientific credibility: a practical guide to reducing conflicts of interest

Electrochemical advanced oxidation processes: A review on their application to synthetic and real wastewaters

Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Monocarboxylate Transporters: Therapeutic Targets and Prognostic Factors in Disease

A Qualitative Meta-Analysis Reveals Consistent Effects of Atrazine on Freshwater Fish and Amphibians

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis

Challenges and Opportunities for Electrochemical Processes as Next-Generation Technologies for the Treatment of Contaminated Water

Synthesis, characterization, and biomedical assessment of novel bisimidazole–coumarin conjugates

Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients

Atrazine Affects Phosphoprotein and Protein Expression in MCF-10A Human Breast Epithelial Cells

Chemical Pesticides and Human Health: The Urgent Need for a New Concept in Agriculture

Influence of Dietary Ascorbic Acid on the Immune Responses of Juvenile Korean Rockfish Sebastes schlegelii

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All‐Cause Mortality: A Systematic Review and Meta‐analysis of Randomized Controlled Trials

Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literature

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

Rapid exclusion of the diagnosis of immune HIT by AcuStar HIT and heparin-induced multiple electrode aggregometry

Platelet microparticle generation assay: A valuable test for immune heparin-induced thrombocytopenia diagnosis

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays

Impact of dabigatran on a large panel of routine or specific coagulation assays

Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: A retrospective study

Combined effects of herbicides on biomarkers reflecting immune–endocrine interactions in goldfishImmune and antioxidant effects